EXHIBIT 10.2


 


AMENDMENT
NO. THREe TO Loan and Security Agreement and consent


 


This Amendment No.
Three to Loan and Security Agreement and Consent (this “Agreement”), dated as of March 18, 2021 (the
“Amendment No. Three Effective Date”), is entered into among Danimer Scientific Holdings, LLC, a Delaware
limited liability company (“Danimer Holdings”), Meredian Bioplastics, Inc., a Georgia corporation (“Meredian
Bioplastics”; and together with Danimer Holdings, each a “Borrower” and collectively the
“Borrowers”), Meredian, Inc., a Georgia corporation (“Meredian”), Danimer Scientific,
L.L.C., a Georgia limited liability company “Danimer Scientific”), Danimer Bioplastics, Inc., a Georgia
corporation (“Danimer Bioplastics”), Danimer Scientific Kentucky, Inc., a Delaware corporation (“Danimer
Kentucky”; together with Meredian, Danimer Scientific, Danimer Bioplastics and with any other Person that at any
time after the date hereof becomes a Guarantor, each a “Guarantor” and collectively, the “Guarantors”,
and together with the Borrowers, the “Loan Parties”), the several entities from time to time party thereto
as Lenders, and Southeast Community Development Fund X, L.L.C., a Delaware limited liability company, as Administrative Agent (“Administrative
Agent”).


 


Recitals:


 


A. Borrowers,
the Affiliates of Borrowers from time to time party thereto as Guarantors, the entities from time to time party thereto as Lenders
and Administrative Agent are party to that certain Loan and Security Agreement, dated as of March 13, 2019, as supplemented by
that certain Waiver Letter Agreement dated July 28, 2020, as amended by Amendment No. One to Loan and Security Agreement dated
as of October 2, 2020, and as amended by Amendment No. Two to Loan and Security Agreement dated as of December 22, 2020 (as amended
from time to time, the “Existing Loan Agreement”, as the same is amended pursuant to this Agreement and
as it may be further amended, supplemented and/or otherwise modified from time to time, the “Loan Agreement”).


 


B. Borrowers
have requested that Lenders (a) amend the interest rate, including that interest accrue at LIBOR rather than a rate based upon
the Prime Rate, and (b) relinquish their board observer rights as provided herein, on and subject to the terms and conditions set
forth herein. Administrative Agent, on behalf of and at the direction of Required Lenders, is willing to agree to the requests
of Borrowers, so long as the Loans may not be prepaid prior to July 1, 2022, and on the further terms and conditions set forth
herein.


 


C. Borrowers
have requested that Lenders (a) further amend the Existing Loan Agreement as hereinafter set forth, (b) waive certain financial
statement delivery requirements as hereinafter set forth, and (c) acknowledge the exercise of an Equity Cure Right as hereinafter
set forth.


 


Agreement:


 


NOW, THEREFORE, in
consideration of the premises and the mutual covenants and conditions contained herein, and for good and valuable consideration,
the receipt and sufficiency of which are hereby specifically acknowledged, the parties hereby covenant and agree as follows:


 


1. Definitions;
References; Interpretation.


 


(a) Unless
otherwise specifically defined herein, each capitalized term used herein (including in the Recitals hereof) that is defined in
the Loan Agreement shall have the meaning assigned to such term in the Loan Agreement.


 


(b) Each
reference to “this Agreement,” “hereof,” “hereunder,” “herein” and “hereby”
and each other similar reference contained in the Loan Agreement, and each reference to “the Loan Agreement” and each
other similar reference in the other Loan Documents, shall from and after the date of this Agreement, refer to the Loan Agreement,
as amended hereby. This Agreement is a Loan Document.


 


(c) The
rules of interpretation set forth in Section 1.02 of the Loan Agreement shall be applicable to this Agreement, mutatis mutandis.


 




     


     


    

 


2. Acknowledgments
of Obligations and Related Matters.


 


(a) Acknowledgment
of Obligations. Borrowers hereby acknowledge, confirm and agree that Borrowers are, jointly and severally, unconditionally
indebted to Administrative Agent and Lenders as of the close of business on the date preceding the date hereof in respect of the
Loans and all other Obligations in the aggregate principal amount of not less than $9,999,980.00, together with interest accrued
and accruing thereon, and all fees, costs, expenses and other sums and charges now or hereafter payable by Borrowers to Administrative
Agent and Lenders pursuant to the Loan Agreement and the other Loan Documents, all of which are unconditionally owing by Borrowers
to Administrative Agent and Lenders pursuant to the Loan Documents, in each case without offset, defense or counterclaim of any
kind, nature or description whatsoever.


 


(b) Acknowledgment
of Security Interests. Borrowers hereby acknowledge, confirm and agree that Administrative Agent and Lenders have, and shall
continue to have, valid, enforceable and perfected security interests in and liens upon the Collateral heretofore granted by Borrowers
to Administrative Agent, for the benefit of Lenders, pursuant to the Loan Documents or otherwise granted to or held by Administrative
Agent.


 


(c) Binding
Effect of Loan Documents. Borrowers hereby acknowledge, confirm and agree that: (i) each of the Loan Documents to which any
Borrower is a party has been duly executed and delivered to Administrative Agent and Lenders by such Borrower and each is in full
force and effect as of the date hereof, (ii) the agreements and obligations of Borrowers contained in such Loan Documents to which
any Borrower is a party and in this Agreement constitute the legal, valid and binding Obligations of Borrowers, enforceable against
Borrowers in accordance with their respective terms, except as enforcement may be limited by bankruptcy, insolvency, reorganization,
moratorium or other similar laws relating to or limiting creditors’ rights generally or by equitable principles relating
to enforceability, and Borrowers have no valid defense to the enforcement of such Obligations, and (iii) Administrative Agent and
Lenders are and shall be entitled to the rights, remedies and benefits provided for in the Loan Documents and pursuant to applicable
law, but subject to the terms and conditions of this Agreement.


 


3. Modifications
to the Loan Agreement. Upon the effectiveness of this Agreement in accordance with the provisions hereof and notwithstanding
anything to the contrary contained in the Existing Loan Agreement or the Loan Documents:


 


(a) Modification
of Certain Defined Terms Under Section 1.01 of the Existing Loan Agreement. Section 1.01 of the Existing Loan Agreement, titled
Certain Defined Terms, is hereby modified as of the Amendment No. Three Effective Date to amend and restate in their entirety the
following defined terms contained therein to read as follows:


 


“Applicable
Margin” means two percent (2.00%).


 


“Default
Rate” means an interest rate equal to the sum of: (a) LIBOR plus the Applicable Margin; plus (b) two percent (2%),
calculated on a per annum basis.


 


“Effective
Date” means March 13, 2019.


 


“Prepayment
Fee” means zero ($0.00).


 


(b) Deletion
and Addition of Certain Defined Terms. Section 1.01 of the Existing Loan Agreement, titled Certain Defined Terms, is hereby
modified as of the Amendment No. Three Effective Date to delete the terms “Base Rate”, “Index Adjustment Date”,
“Observation Party” and “Prime Rate” in their entirety and to add the following terms therein in alphabetical
order:


 


“Benchmark
Replacement” shall mean the sum of: (a) such alternate benchmark rate that has been selected by the Administrative
Agent at the direction of the Required Lenders as the replacement for LIBOR or such other then-current benchmark, giving due consideration
to (i) any selection or recommendation of a replacement benchmark rate or the mechanism for determining such a rate by the Relevant
Governmental Body or (ii) any evolving or then-prevailing market convention for determining a benchmark rate as a replacement for
the then-current benchmark for U.S. dollar-denominated syndicated or bilateral credit facilities at such time and (b) the Benchmark
Replacement Adjustment; provided, that, if the Benchmark Replacement as so determined would be less than zero, the Benchmark
Replacement will be deemed to be zero.


 




    2


     


    

 


“Benchmark
Replacement Adjustment” means, with respect to any replacement of LIBOR with an alternate benchmark rate determined
under clause (a) of the definition of “Benchmark Replacement”, the spread adjustment, or method for calculating or
determining such spread adjustment, (which may be a positive or negative value or zero) that has been selected by the Administrative
Agent at the direction of the Required Lenders, giving due consideration to (i) any selection or recommendation of a spread adjustment,
or method for calculating or determining such spread adjustment, for the replacement of LIBOR with such alternate benchmark rate
by the Relevant Governmental Body or (ii) any evolving or then-prevailing market convention for determining a spread adjustment,
or method for calculating or determining such spread adjustment, for the replacement of LIBOR with such alternate benchmark rate
for U.S. dollar-denominated syndicated or bilateral credit facilities at such time.


 


“Benchmark
Replacement Date” shall mean the earlier to occur of the following events with respect to LIBOR:


 


(a) in
the case of clause (a) or (b) of the definition of “Benchmark Transition Event,” the later of (i) the
date of the public statement or publication of information referenced therein and (ii) the date on which the administrator of LIBOR
permanently or indefinitely ceases to provide LIBOR; and 


 


(b) in
the case of clause (c) of the definition of “Benchmark Transition Event,” the date of the public statement or
publication of information referenced therein.


 


“Benchmark
Transition Event” shall mean the occurrence of one or more of the following events with respect to LIBOR:


 


(a) a
public statement or publication of information by or on behalf of the administrator of LIBOR announcing that such administrator
has ceased or will cease to provide LIBOR, permanently or indefinitely, provided, that, at the time of such statement or
publication, there is no successor administrator that will continue to provide LIBOR;


 


(b) a
public statement or publication of information by the regulatory supervisor for the administrator of LIBOR, the U.S. Federal Reserve
System, an insolvency official with jurisdiction over the administrator for LIBOR, a resolution authority with jurisdiction over
the administrator for LIBOR or a court or an entity with similar insolvency or resolution authority over the administrator for
LIBOR, which states that the administrator of LIBOR has ceased or will cease to provide LIBOR permanently or indefinitely, provided,
that, at the time of such statement or publication, there is no successor administrator that will continue to provide LIBOR; or


 


(c) a
public statement or publication of information by the regulatory supervisor for the administrator of LIBOR announcing that LIBOR
is no longer representative and such circumstances are unlikely to be temporary.


 


“Benchmark
Transition Start Date” shall mean in the case of a Benchmark Transition Event, the earlier of (i) the applicable
Benchmark Replacement Date and (ii) if such Benchmark Transition Event is a public statement or publication of information of a
prospective event, the 90th day prior to the expected date of such event as of such public statement or publication of information
(or, if the expected date of such prospective event is fewer than 90 days after such statement or publication, the date of such
statement or publication).


 




    3


     


    

 


“Interest
Accrual Period” shall mean for each Interest Payment Date, the period beginning on and including the immediately
preceding Interest Payment Date and ending on and including the day immediately preceding such Interest Payment Date.


 


“LIBOR”
means, for any Interest Accrual Period, an interest rate per annum equal to the rate appearing on the applicable Bloomberg screen
page (the “Service”) (or on any successor or substitute page of the Service providing rate quotations comparable
to those currently provided on such page of the Service, as reasonably determined by the Administrative Agent from time to time
for purposes of providing quotations of interest rates applicable to Dollar deposits in the London interbank market) at approximately
11:00 A.M., London time, on the date two (2) Business Days preceding the commencement of such Interest Accrual Period, as the rate
for Dollar deposits with a maturity of one (1) month; provided, that if at any time LIBOR shall be less than zero, then
LIBOR shall be deemed to be zero at such time.


 


“Relevant
Governmental Body” means the Board of Governors of the Federal Reserve System or the Federal Reserve Bank of New
York, or a committee officially endorsed or convened by the Board of Governors of the Federal Reserve System or the Federal Reserve
Bank of New York, or any successor thereto.


 


(c) Modification
of Section 2.02(a) of the Existing Loan Agreement. Section 2.02 of the Existing Loan Agreement, titled Interest, is hereby
modified as of the Amendment No. Three Effective Date to restate subsection (a) thereof in its entirety as follow:


 


(a) Interest.
Subject to the provisions hereof (including Section 2.02(b) and (d)), commencing on March 1, 2021 and continuing until each
Loan is paid in full, each Loan shall bear interest at LIBOR plus the Applicable Margin, payable in cash. Notwithstanding the foregoing,
if a Benchmark Transition Event and its related Benchmark Replacement Date have occurred with respect to LIBOR, then the Benchmark
Replacement shall replace LIBOR for all purposes hereunder and the Loans shall accrue interest at the Benchmark Replacement plus
the Applicable Margin; provided, that, no replacement of LIBOR with a Benchmark Replacement pursuant to this Section
2.02(a) will occur prior to the applicable Benchmark Transition Start Date. LIBOR shall be determined each month for each Interest
Accrual Period, two (2) Business Days preceding the commencement of such Interest Accrual Period, as set forth in the definition
of LIBOR. Any Benchmark Replacement that may be in effect shall be determined as frequently as is directed by the Administrative
Agent, at the direction of the Required Lenders.


 


(d) Modification
of Section 2.03(b) of the Existing Loan Agreement. Section 2.03 of the Existing Loan Agreement, titled Voluntary Prepayments
of the Loan, is hereby modified as of the Amendment No. Three Effective Date to restate subsection (b) thereof in its entirety
as follows:


 


(b) Voluntary
Prepayments of the Loans. Borrowers shall not be permitted to voluntarily prepay or repay the Loans (or any portion thereof)
until after July 1, 2022. After July 1, 2022, Borrowers may voluntarily prepay the Outstanding Amount of the Loans in whole or
in part, upon not less than thirty (30) days prior irrevocable written notice to Administrative Agent, which notice shall state
the Outstanding Amount of the Loans being prepaid. Voluntary prepayments shall be in a minimum amount of Two Hundred Fifty Thousand
Dollars ($250,000) or an integral multiple of Fifty Thousand Dollars ($50,000) in excess thereof (or, if less, the entire Outstanding
Amount of the Loans) In connection with any such voluntary prepayment, Borrowers shall pay the sum of: (i) the Outstanding Amount
of the Loans being prepaid; plus (ii) accrued unpaid interest at the rate then applicable to the Loans on the amounts prepaid in
the immediately preceding clause (i), through the date of such voluntary prepayment. Administrative Agent, at the direction of
the Required Lenders, shall determine which Loan to apply each prepayment of the Loans. All prepayments of the Loans made pursuant
to this Section 2.03(b) shall not reduce the mandatory prepayments of the Loans otherwise required pursuant to Section
2.03(c).


 




    4


     


    

 


(e) Modification
of Section 2.03(c)(v) of the Existing Loan Agreement. Section 2.03(c) of the Existing Loan Agreement, titled Mandatory Repayments
of the Loans, is hereby modified as of the Amendment No. Three Effective date to restate subsection (v) thereof in its entirety
as follows:


 


(v) Reserved.


 


(f) Modification
of Section 6.02(j) of the Existing Loan Agreement. Section 6.02 of the Existing Loan Agreement, titled Certificates; Other
Information, is hereby modified as of the Amendment No. Three Effective Date to restate subsection (j) thereof in its entirety
as follows:


 


(j) Reserved.


 


(g) Modification
of Section 6.13 of the Existing Loan Agreement. Section 6.13 of the Existing Loan Agreement, titled Financial Covenants, is
hereby modified as of the Amendment No. Three Effective Date to add a new subsection (d) thereto to read in its entirety as follows:


 


(d) Notwithstanding
anything to the contrary contained herein or in any other Loan Document, for so long as Danimer Holdings has Qualified Cash in
an amount of not less than $10,000,000 the Loan Parties and their Subsidiaries shall not be required to comply with the specific
financial covenants contained in subsections (a), (b) and (c) of this Section 6.13.


 


(h) Modification
of Section 6.18 of the Existing Loan Agreement. Section 6.18 of the Existing Loan Agreement, titled Board Observation Rights,
is hereby modified as of the Amendment No. Three Effective Date to restate it in its entirety as follows:


 


Section
6.18 Reserved.


 


(i) Modification
of Section 7.07 of the Existing Loan Agreement. Section 7.07 of the Existing Loan Agreement, titled Capital Expenditures, is
hereby modified as of the Amendment No. Three Effective Date to restate such section in its entirety as follows:


 


Section
7.07. CAPITAL EXPENDITURES.


 


Make (whether in one transaction
or a series of transactions) any financed or unfinanced Capital Expenditures in an aggregate amount for Loan Parties and their
Subsidiaries during any period set forth below in an aggregate amount more than the amount specified for the end of such period
set forth below; provided, however, that any Capital Expenditures made with the proceeds of a Specified Equity Contribution shall
not be counted for purposes of the limitation in this Section 7.07.


 


	Calendar Year	 	Maximum Capital Expenditures	 
	For the Fiscal Year ending December 31, 2019	 	$	29,600,000	 
	For the Fiscal Year ending December 31, 2020	 	$	7,500,000	 
	For the Fiscal Year ending December 31, 2021	 	$	7,500,000	 
	For the Fiscal Year ending December 31, 2022	 	$	5,500,000	 
	For the Fiscal Year ending December 31, 2023 and each Fiscal Year thereafter	 	$	5,500,000	 



 




    5


     


    

 


If Loan Parties and their Subsidiaries
do not utilize the entire amount of such Capital Expenditures permitted in any Fiscal Year, Loan Parties and their Subsidiaries
may carry forward to the immediately succeeding Fiscal Year only, 100% of such unutilized amount (with such Capital Expenditures
made by Loan Parties and their Subsidiaries in such succeeding Fiscal Year applied first to such carried-forward amount).


 


Notwithstanding anything to the
contrary contained herein or in any other Loan Document, for so long as Danimer Holdings has Qualified Cash in an amount of not
less than $10,000,000 the Loan Parties and their Subsidiaries shall not be required to comply with the Capital Expenditures limitations
contained in this Section 7.07.


 


(j) Modification
of Section 8.03(a) of the Existing Loan Agreement. Section 8.03 of the Existing Loan Agreement, titled Equity Cure Rights,
is hereby modified as of the Amendment No. Three Effective Date to restate subsection (a) thereof in its entirety as follows:


 


(a) Administrative
Loan Party shall deliver to Administrative Agent irrevocable written notice of its intent to cure a Financial Covenant Default
(a “Cure Notice”) no later than five (5) Business Days after the date on which financial statements and
a Compliance Certificate for the period ending on the last day of the Fiscal Quarter with respect to which such Financial Covenant
Default occurred (the “Testing Date”) are required to be delivered. The Cure Notice shall set forth the
calculation of the applicable cure amount in subsection (b) below and shall specify the amount of any Specified Equity Contribution
relating to such Financial Covenant Default for such Fiscal Quarter and the amount of any Specified Equity Contribution that may
be applied to fund Capital Expenditures and not counted toward the limitation set forth in Section 7.07.


 


(k) Modification
of Section 8.03(b) of the Existing Loan Agreement. Section 8.03 of the Existing Loan Agreement, titled Equity Cure Rights,
is hereby modified as of the Amendment No. Three Effective Date to restate subsection (b) thereof in its entirety as follows:


 


(b) Borrowers
shall cause Parent, at any time during the period commencing on the first day of a Fiscal Quarter in which a Financial Covenant
Default occurred or is anticipated to occur and ending no later than ten (10) Business Days after the date on which financial statements
and a Compliance Certificate for the period ending on the Testing Date are required to be delivered (the “Required
Contribution Date”), to make cash capital contributions to Danimer Holdings (any such cash equity contribution, a
“Specified Equity Contribution”), which, for the avoidance of doubt, may include Specified Equity Contributions,
as set forth in the Cure Notice, made by Parent to Danimer Holdings during the period commencing on the first day of the Fiscal
Quarter in which a Financial Covenant Default occurred and ending on the Required Contribution Date, in an amount pertaining to
the Financial Covenant Default that is equal to or, if elected by the Borrowers, greater than:


 


(i) the product
obtained by multiplying (A) the amount by which the Consolidated Adjusted EBITDA on the Testing Date is less than the minimum Consolidated
Adjusted EBITDA that would need to be then existing in order for the Borrowers to be in pro forma compliance with the minimum Consolidated
Adjusted EBITDA covenant contained in Section 6.13(a) as of such Testing Date (such amount, the “EBITDA Covenant
Cure Amount”), by (B) 110%, for a Financial Covenant Default of the minimum Consolidated Adjusted EBITDA covenant;


 




    6


     


    

 


(ii) the
product obtained by multiplying (A) the amount by which the Consolidated Adjusted EBITDA on the Testing Date is less than the minimum
Consolidated Adjusted EBITDA that would need to be then existing in order for the Borrowers to be in pro forma compliance with
the minimum Consolidated Fixed Charge Coverage Ratio contained in Section 6.13(b) as of such Testing Date (such amount,
the “Fixed Charge Coverage Ratio Cure Amount”), by (B) 110%, for a Financial Covenant Default of the
minimum Consolidated Fixed Charge Coverage Ratio; and/or


 


(iii) the
product obtained by multiplying (A) the amount by which the aggregate Consolidated Funded Debt outstanding on the Testing Date
exceeds the maximum amount of Consolidated Funded Debt that would need to be then outstanding in order for the Borrowers to be
in pro forma compliance with the maximum Consolidated Leverage Ratio contained in Section 6.13(c) as of such Testing Date
(such amount, the “Leverage Covenant Cure Amount”), by (B) 110%, for a Financial Covenant Default of
the maximum Consolidated Leverage Ratio.


 


In the case of clauses (i) or
(ii) above, the Specified Equity Contribution shall be deemed added to Consolidated Adjusted EBITDA for the period in which the
Loan Parties were out of compliance with the Consolidated Fixed Charge Coverage Ratio, the minimum Consolidated Adjusted EBITDA
covenant, or the maximum Consolidated Leverage Ratio, as applicable, and shall continue to be an addition to Consolidated Adjusted
EBITDA for four consecutive Fiscal Quarters beginning with the Fiscal Quarter in which the Specified Equity Contribution was initially
added to Consolidated Adjusted EBITDA.


 


(l) Modification
of Section 8.03(c) of the Existing Loan Agreement. Section 8.03 of the Existing Loan Agreement, titled Equity Cure Rights,
is hereby modified as of the Amendment No. Three Effective Date to restate subsection (c) thereof in its entirety as follows:


 


(c) Reserved.


 


(m) Modification
of Section 10.02 of the Existing Loan Agreement. Section 10.02 of the Existing Loan Agreement, listing Notices addresses, is
hereby modified to delete the Schedule 10.02 attached to the Existing Loan Agreement and replace such schedule with the
Schedule 10.02 attached hereto as Attachment I.


 


4. Waiver.
Notwithstanding that the Administrative Loan Party has failed to furnish to Administrative Agent unaudited financial statements
for the Fiscal Month ending December 31, 2020 and a Compliance Certificate therewith within forty-five (45) days as required by
Section 6.03(c) of the Existing Loan Agreement (the “Financial Delivery Requirement”), the undersigned Required
Lenders and Administrative Agent hereby waive compliance with the Financial Delivery Requirement, subject to delivery of the unaudited
financial statements for the Fiscal Month ending December 31, 2020 and a Compliance Certificate therewith by March 31, 2021.


 


5. Equity
Cure Acknowledgment. In connection with the execution and delivery of this Agreement, Administrative Agent and the Required
Lenders acknowledge and agree that after giving effect to the Specified Equity Contributions in the aggregate amount of $15,622,647
made by Parent to Danimer Holdings during the Fiscal Quarter ending December 31, 2020, the Loan Parties and their Subsidiaries
are in compliance with the financial covenants set forth in Section 6.13 of the Existing Loan Agreement for the Fiscal Quarter
ending December 31, 2020; and, after giving effect to the Specified Equity Contribution in the aggregate amount of $46,927,647
made by Parent to Danimer Holdings during the Fiscal Year ending December 31, 2020, the Loan Parties and their Subsidiaries are
in compliance with the Maximum Capital Expenditures covenant set forth in Section 7.07 of the Existing Loan Agreement for the Fiscal
Year ending December 31, 2020.


 




    7


     


    

 


6. Representations
and Warranties. Each Borrower hereby represents and warrants to Administrative Agent and Lenders as follows:


 


(a) No
Default or Event of Default has occurred and is continuing (or would result from the amendment of the Existing Loan Agreement contemplated
hereby), after giving effect to this Agreement.


 


(b) The
execution, delivery and performance by each Loan Party of this Agreement has been duly authorized by all necessary corporate and
other action and do not and will not require any registration with, consent or approval of, or notice to or action by, any Person
other than such as have been obtained or made and are in full force and effect.


 


(c) On
and as of the date of this Agreement, all representations and warranties of each Loan Party contained in the Loan Agreement and
in each other Loan Document are true and correct in all material respects (except to the extent such representations and warranties
expressly refer to an earlier or specified date, in which case they are true and correct in all material respects as of such earlier
or specified date).


 


7. Conditions
of Effectiveness.


 


(a) The
Agreement shall become effective as of the Amendment No. Three Effective Date upon the satisfaction of all of the following conditions:


 


(i) Borrowers
shall have delivered to Administrative Agent an original (or executed faxed or electronic copy) of this Agreement, duly executed
by each of the Loan Parties;


 


(ii) Parent
shall have delivered to Administrative Agent an original (or executed faxed or electronic copy) of the Ratification attached to
this Amendment, duly executed by Parent;


 


(iii) Borrowers,
Guarantors and Parent shall deliver to Administrative Agent an Officers’ Certificate of the Parent, Meredian Holdings Group,
Inc., a Delaware corporation, certifying as to (I) its articles of incorporation (attaching a certified articles from such state
of a recent date), (II) its current bylaws (and attaching same), (III) resolutions approving this Amendment and the Ratification,
as applicable, and approving and ratifying all prior Amendments (as such term is defined in the Ratification), (IV) its officers
authorized to execute this Amendment or the Ratification and specimen signatures of such officers, and (V) its good standing in
its state incorporation (attaching a certified certificate from such state of a recent date) and confirming its good standing in
each other state where it is required to be registered as a foreign corporation, except where the failure to be so qualified would
not have a Material Adverse Effect;


 


(iv) each
of the representations and warranties contained in Section 4 of this Agreement shall be true, correct and accurate as of the date
of this Agreement; and


 


(v) the
receipt by Administrative Agent of the payment, in immediately available funds, of all reasonable out-of-pocket fees, costs, charges
and expenses incurred by Administrative Agent in connection with the preparation, execution and delivery of this Agreement or any
of the transactions arising hereunder or otherwise related hereto or referred to herein, including any actual out-of-pocket costs,
expenses, charges or expenses of Administrative Agent and the reasonable fees, charges and disbursements of counsel for Administrative
Agent.


 




    8


     


    

 


(b) The
parties hereto specifically acknowledge and agree that: (i) the execution and delivery of this Agreement shall not be deemed to
create a course of dealing or otherwise obligate Administrative Agent or Lenders to execute similar agreements under the same,
similar or different circumstances in the future; and (ii) neither Administrative Agent nor any Lender has any obligation to further
amend provisions of, or waive compliance with or consent to a departure from the requirements of, the Existing Loan Agreement or
any of the other Loan Documents. Except as expressly amended pursuant hereto, the Existing Loan Agreement and each of the other
Loan Documents shall remain unchanged and in full force and effect and are hereby ratified and confirmed in all respects, and the
Collateral described in the Loan Documents shall continue to secure the Obligations. Each of the Guarantors party hereto: (i) specifically
consents to the terms of this Agreement; (ii) reaffirms its obligations under its Guaranty and under all other Loan Documents to
which it is a party; (iii) reaffirms the waivers of each and every one of the defenses to such obligations as set forth in such
Guaranty and each such other Loan Document; and (iv) reaffirms that its obligations under such Guaranty and each such other Loan
Document are separate and distinct from the obligations of any other party under the Loan Documents.


 


8. General
Release. On and as of the Amendment No. Three Effective Date and in consideration of the agreements set forth herein, Parent
and each Loan Party which is a party hereto, on behalf of itself and its successors and assigns, does hereby: (a) release, acquit
and forever discharge Administrative Agent and each Lender, all of Administrative Agent’s and each Lender’s predecessors-in-interest,
and all of Administrative Agent’s and each Lender’s past and present officers, directors, managers, members, attorneys,
affiliates, employees and agents, of and from any and all claims, demands, obligations, liabilities, indebtedness, breaches of
contract, breaches of duty or of any relationship, acts, omissions, misfeasance, malfeasance, causes of action, defenses, offsets,
debts, sums of money, accounts, compensation, contracts, controversies, promises, damages, costs, losses and expenses, of every
type, kind, nature, description or character, whether known or unknown, suspected or unsuspected, liquidated or unliquidated (each
of the foregoing, a “Claim”), each as though fully set forth herein at length, that any Borrower, any
Loan Party or any of their respective successors or assigns now has or may have as of the Amendment No. Three Effective Date in
any way arising out of, connected with or related to any or all of the transactions contemplated by the Loan Documents (including
this Agreement) or any of them or any provision or failure to provide credit or other accommodations to any Borrower or any other
Person under the Loan Documents (including this Agreement) or any of them or any other agreement, document or instrument referred
to, or otherwise related to, any or all of the Loan Documents (including this Agreement) or any of them (each, a “Released
Claim”); and (b) specifically acknowledge and agree that: (i) none of the provisions of the release contained in
Section 6(a) above (the “General Release”) shall be construed as or constitute an admission of any liability
on the part of Administrative Agent or Lenders (or any of them); (ii) the provisions of the General Release shall constitute an
absolute bar to any Released Claim of any kind, whether any such Released Claim is based on contract, tort, warranty, mistake or
any other theory, whether legal, statutory or equitable; and (iii) any attempt to assert a Released Claim barred by the provisions
of the General Release shall subject it to the provisions of applicable law setting forth the remedies for the bringing of groundless,
frivolous or baseless claims or causes of action.


 


9. General
Provisions.


 


(a) This
Agreement shall be binding upon and inure to the benefit of the parties to the Loan Agreement and their respective successors and
assigns.


 


(b) This
Agreement may be executed in any number of counterparts, each of which shall be deemed an original, but all such counterparts together
shall constitute but one and the same instrument. Each of the parties hereto understands and agrees that this document (and any
other document required herein) may be delivered by the other party thereto either in the form of an executed original or an executed
original sent by facsimile or electronic transmission to be followed promptly by mailing of a hard copy original, and that receipt
by Administrative Agent of an electronically, telecopier facsimile or other portable document format purportedly bearing the signature
of Borrowers and shall bind Borrowers with the same force and effect as the delivery of a hard copy original.


 


(c) This
Agreement contains the entire and exclusive agreement of the parties to the Loan Agreement with reference to the matters discussed
herein. This Agreement supersedes all prior drafts and communications with respect hereto. This Agreement may not be amended except
in accordance with the provisions of the Loan Agreement.


 


(d) Article
X of the Existing Loan Agreement (except Section 10.14 thereof) is incorporated herein by this reference and made applicable as
if set forth herein in full, mutatis mutandis.


 


[Remainder
of page intentionally left blank.]


 




    9


     


    

 


In
Witness Whereof, the parties hereto have duly executed and delivered this Agreement as of the date first written above.


 


	BORROWERS:	 	 
	 	 	 
	DANIMER SCIENTIFIC HOLDINGS, LLC	 	MEREDIAN BIOPLASTICS, INC.


 


	By:	/s/ John A. Dowdy, III	 	By:	/s/ John A. Dowdy, III
	Name:	John A. Dowdy, III	 	Name:	John A. Dowdy, III
	Title:	Chief Financial Officer	 	Title:	Chief Financial Officer


 


	GUARANTORS:	 	 
	 	 	 
	MEREDIAN, INC.	 	DANIMER SCIENTIFIC, L.L.C.


 


	By:	/s/ John A. Dowdy, III	 	By:	/s/ John A. Dowdy, III
	Name:	John A. Dowdy, III	 	Name:	John A. Dowdy, III
	Title:	Chief Financial Officer	 	Title:	Chief Financial Officer


 


	DANIMER BIOPLASTICS, INC.	 	DANIMER SCIENTIFIC KENTUCKY, INC.


 


	By:	/s/ John A. Dowdy, III	 	By:	/s/ John A. Dowdy, III
	Name:	John A. Dowdy, III	 	Name:	John A. Dowdy, III
	Title:	Chief Financial Officer	 	Title:	Chief Financial Officer


 


[Signatures continue on following page]


 


Amendment No. Three to LSA and Consent (Danimer/SECDF
X/PIFS)


 




     


     


    

 


Administrative Agent:


 


SOUTHEAST COMMUNITY DEVELOPMENT 

FUND X, L.L.C.,

a Delaware limited liability company


 


	By:	Advantage Capital Community Development 

Fund, L.L.C., its Managing Member


 


	By:	/s/ Abhi Chandrasekhara	 
	Name:	Abhi Chandrasekhara	 
	Title:	Authorized Person	 


 


Amendment No. Three to LSA and Consent (Danimer/SECDF
X/PIFS)


 




     


     


    

 


Lenders:


 


Southeast Community
Development 

Fund X, L.L.C.,


a Delaware limited liability company


 


	By:	Advantage Capital Community Development 

Fund, L.L.C., its Managing Member


 


	By:	/s/ Abhi Chandrasekhara	 
	Name:	Abhi Chandrasekhara	 
	Title:	Authorized Person	 


 


[Signatures
continue on following page]


 


Amendment No. Three to LSA and Consent (Danimer/SECDF
X/PIFS)


 




     


     


    

 


LENDERS (CONT.):


 


PIFS SUb-CDE XX,
LLC,


a Virginia limited liability company


 


	By:	People Incorporated Financial Services, a Virginia 

non-stock corporation, its Managing Member


 


	By:	/s/ Robert G. Goldsmith	 
	Name:	Robert G. Goldsmith	 
	Title:	President and CEO	 


 


Amendment No. Three to LSA and Consent (Danimer/SECDF
X/PIFS)


 




     


     


    

 


Attachment I


 


Schedule
10.02


 


Administrative Agent’s Office;
Certain Addresses for Notices


 


If to Loan Parties:


 


c/o Danimer Scientific Holdings, LLC

140 Industrial Boulevard

Bainbridge, Georgia 39817

Facsimile:


		Email Address:	croskrey@danimer.com



Attention: Stephen E. Croskrey, CEO


 


with a copy to (which shall not constitute notice):


 


Kane Kessler, P.C.

600 Third Avenue, 35th Floor

New York, New York 10016

Facsimile: 212-245-3009


		Email Address:	rlawrence@kanekessler.com



Attention: Robert L. Lawrence, Esq.


 


If to Administrative Agent or SECDF:


 


Southeast Community
Development Fund X, L.L.C.

909 Poydras Street, Suite 2230

New Orleans, LA 70112

Attention:Anthony Billings and Gabriel Rosen


		Email Address:	abillings@advantagecap.com



		Email Address:	grosen@advantagecap.com



 


with a copy to (which shall not constitute notice):


 


Dentons US LLP


One Metropolitan Square


211 N. Broadway, Suite 3000


St. Louis, MO 63102-2741


		Attention:	Amelia Lewis, Esq.



		Email Address:	amelia.lewis@dentons.com



 


Dentons US LLP

303 Peachtree Street, Suite 5300

Atlanta, GA 30308


		Attention:	Carolyn Richter, Esq.



		Email Address:	carolyn.richter@dentons.com



 


If to PIFS:


 


PIFS Sub-CDE XX, LLC

1173 West Main Street

Abingdon, VA 24210


		Facsimile:	276-628-2931



		Attention:	Bryan Phipps



 




     


     


    

 


with a copy to (which shall not constitute notice)


 


Southeast Community Development Fund X, L.L.C.

909 Poydras Street, Suite 2230

New Orleans, LA 70112

Attention:Anthony Billings and Gabriel Rosen


		Email Address:	abillings@advantagecap.com



		Email Address:	grosen@advantagecap.com



 


with a copy to (which shall not constitute notice):


 


Dentons US LLP


One Metropolitan Square


211 N. Broadway, Suite 3000


St. Louis, MO 63102-2741


		Attention:	Amelia Lewis, Esq.



		Email Address:	amelia.lewis@dentons.com



 


Dentons US LLP

303 Peachtree Street, Suite 5300

Atlanta, GA 30308


		Attention:	Carolyn Richter, Esq.



		Email Address:	carolyn.richter@dentons.com



 







     


     


    

 


RATIFICATION BY GUARANTOR


 


The undersigned, Meredian
Holdings Group, Inc., a Delaware corporation (“Parent”), hereby states as follows to and for the benefit of
Administrative Agent and each Lender, in each case as of the date hereof:


 


(i) acknowledges
the execution of the foregoing Amendment No. 3 to Loan and Security Agreement by each Loan Party and of each prior amendment to
and consent and waiver given in connection with the Loan Agreement, including without limitation Amendment No. One to Loan and
Security Agreement, dated as of October 2, 2020, Amendment No. Two to Loan and Security Agreement and Consent, dated as of December
22, 2020, Waiver Letter Agreement, dated July 28, 2020, and Consent to Prepay the White Oak Facility in full, dated January 28,
2021 (collectively, the “Amendments”), copies of which have been reviewed by Parent;


 


(ii) ratifies
the terms and provisions of the Parent Guaranty and the Parent Pledge Agreement executed by the undersigned pursuant to the Loan
Agreement;


 


(iii) confirms
that for purposes of the Parent Guaranty and the Parent Pledge Agreement, the term “Loan Agreement” includes all of
the terms, conditions and obligations of each Borrower and Guarantor set forth in the Amendments and any future amendments executed
in accordance with the terms of the Loan Agreement;


 


(iv) affirms
that (a) its obligations under Parent Guaranty and the Parent Pledge Agreement remain valid and in full force and effect in accordance
with the terms of the Parent Guaranty and the Parent Pledge Agreement, respectively, (b) no Default or Event of Default has occurred
and is continuing (or would result from the foregoing Amendments) and (c) all of Parent’s representations and warranties
contained in the Parent Guaranty and Parent Pledge Agreement and any other Loan Document to which Guarantor is a party are true
and correct in all material respects (except to the extent such representations and warranties expressly refer to an earlier or
specified date, in which case they are true and correct in all material respects as of such earlier or specified date), after giving
effect to the Amendments; and


 


(v) confirms
that (a) Administrative Agent has a first-priority perfected security interest in all the limited liability company interests owned
by Parent in Danimer Scientific Holdings, LLC, a Delaware limited liability company (“Danimer Holdings”), by
possession, assuming the continued possession by Administrative Agent of the equity certificate no. 1 evidencing 100% of the member
interests in Danimer Holdings and a limited liability company power undated and signed in blank, which was or shall be promptly
delivered to Administrative Agent on behalf of Parent, and by the filing of UCC financing statement no. 2021 2113182 filed in the
office of the Secretary of State of the State of Delaware on March 17, 2021, and (b) the limited liability company agreement of
Danimer Holdings contains each of the provisions set forth in Schedule III to the Parent Pledge Agreement required on and after
the Lien Creation Date pursuant to Section 4 of the Parent Pledge Agreement.


 


Capitalized
terms used herein and not defined herein shall have the meaning given to such terms in the Loan Agreement (as defined in the foregoing
Amendment No. 3 to Loan and Security Agreement).


 


Dated:
March 18, 2021


 


[Signature
on following page]


 




     


     


    

 


	 	PARENT:
	 	 
	 	MEREDIAN HOLDINGS GROUP, INC.


 


	 	By:	 
	 	Name:	 
	 	Title:	 


 


 


Ratification by Guarantor - Amendment No.
3 (Danimer/SECDF X/PIFS)